Goldman Sachs Group Inc Night Hawk Biosciences, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$0.16 - $0.17 $35 - $37
219 Added 1.54%
14,394 $2,000
Q1 2024

May 15, 2024
SELL
$0.15 - $0.45 $301 - $904
-2,009 Reduced 12.41%
14,175 $2,000
Q4 2023

Feb 13, 2024
BUY
$0.26 - $0.51 $354 - $696
1,365 Added 9.21%
16,184 $7,000
Q3 2023

May 14, 2024
SELL
$0.5 - $0.72 $682 - $982
-1,365 Reduced 8.43%
14,819 $7,000
Q3 2023

Nov 14, 2023
SELL
$0.5 - $0.72 $612 - $881
-1,224 Reduced 7.63%
14,819 $7,000
Q2 2023

May 14, 2024
BUY
$0.62 - $0.87 $1,253 - $1,758
2,021 Added 14.41%
16,043 $10,000
Q2 2023

Aug 14, 2023
BUY
$0.62 - $0.87 $1,253 - $1,758
2,021 Added 14.41%
16,043 $10,000
Q1 2023

May 14, 2024
SELL
$0.83 - $1.24 $29 - $44
-36 Reduced 0.26%
14,022 $12,000
Q1 2023

May 11, 2023
SELL
$0.83 - $1.24 $29 - $44
-36 Reduced 0.26%
14,022 $12,000
Q4 2022

May 14, 2024
SELL
$0.77 - $1.62 $1,637 - $3,444
-2,126 Reduced 13.14%
14,058 $11,000
Q4 2022

Feb 13, 2023
BUY
$0.77 - $1.62 $10,824 - $22,773
14,058 New
14,058 $11,000
Q1 2022

May 16, 2022
SELL
$2.1 - $3.54 $118,576 - $199,886
-56,465 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$3.04 - $6.01 $19,085 - $37,730
6,278 Added 12.51%
56,465 $171,000
Q3 2021

Nov 10, 2021
BUY
$5.9 - $7.44 $296,103 - $373,391
50,187 New
50,187 $299,000

Others Institutions Holding NHWK

# of Institutions
1
Shares Held
5K
Call Options Held
0
Put Options Held
0
View Full List

About NightHawk Biosciences, Inc.

NHWK Quotes by TradingView
  • Ticker NHWK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,661,500
  • Market Cap $4.11M
  • Description
  • NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...
More about NHWK
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email